Market Summary | Major Indices | Market Movers | Market Sectors | Mutual Funds | A-Z Stock Listings
ETF Screener | World Markets | Currencies | CEO Wealthmeter | Oil / Energy | Metals
Treasury Rates | Calculators | My Watchlist | My Portfolio
         Symbol Lookup
ALLOS THERAPEUTICS Add to My Watchlist (NSDQ: ALTH) 
Detailed Quote
News
Chart
SEC Filings
Profile
Historical
Options
     Allos 6.94 +0.07 (+1.02%) 435,398
11080 Circlepoint Road
Suite 200
Westminister, CO 80020 US
(303) 426-6262
(303) 412-9160 fax
www.allos.com
CEO Paul L. Berns
Auditor PRICEWATERHOUSECOOPERS LLP
Exchange Traded NQ
ISIN Number US0197771019
CIK Number 1097264
NAICS Code 325412
Business Summary
A biopharmaceutical company focused on developing and commercializing innovative small molecule drugs for the treatment of cancer.
Number of Employees 81
Share Fundamentals
Market Cap 721.35M
Shares Outstanding 103.94M
Float 88.66M
Short Interest 10.77M
Financial Strength
Revenue (TTM) N/A
Earnings (TTM) -$65,365,770
Quick Ratio 7.7:1
Current Ratio 8.1:1
Total Debt/Equity 0:1
Profitability
Gross Margin N/A
EBITDA Margin N/A
Profit Margin N/A
Powered By: FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes.
All other data is delayed at least 20 minutes.
By accessing this page, you agree to the following terms and conditions.
Stock Updates provided by MarketMinute.com
Stock Analysis provided by SocialPicks Conference calls info supplied by OpenCompany
Fundamental data supplied by Mergent, Inc.
Stock quote data supplied by Telekurs